Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

IGF-1 LR3 vs IGF-1 DES: A Related Comparison

Researchers comparing IGF-1 analogs often also encounter IGF-1 DES (DES(1-3) IGF-1), a truncated variant lacking the first three N-terminal amino acids. While DES also shows reduced IGFBP binding, its mechanism and receptor selectivity differ from LR3. A full

This comparison does not assign a generated winner or score.

  • Researchers comparing IGF-1 analogs often also encounter IGF-1 DES (DES(1-3) IGF-1), a truncated variant lacking the first three N-terminal amino acids. While DES also shows reduced IGFBP binding, its mechanism and receptor selectivity differ from LR3. A full comparative analysis is available in: IGF-1 LR3 vs IGF-1 DES: Comparative Analysis for Preclinical Research Protocols.
More references

Related material